Article info

Methylation status of vault RNA 2-1 promoter is a predictor of glycemic response to glucagon-like peptide-1 analog therapy in type 2 diabetes mellitus

Authors

  • Chia-Hung Lin Division of Endocrinology and Metabolism, Department of Internal Medicine, Chang Gung Memorial Hospital, Linkou and College of Medicine, Chang Gung University, Taoyuan, Taiwan PubMed articlesGoogle scholar articles
  • Yun-Shien Lee Genomic Medicine Research Core Laboratory, Chang Gung Memorial Hospital, Linkou Main Branch, Taoyuan, TaiwanDepartment of Biotechnology, Ming Chuan University, Taoyuan, Taiwan PubMed articlesGoogle scholar articles
  • Yu-Yao Huang Division of Endocrinology and Metabolism, Department of Internal Medicine, Chang Gung Memorial Hospital, Linkou and College of Medicine, Chang Gung University, Taoyuan, Taiwan PubMed articlesGoogle scholar articles
  • Chi-Neu Tsai Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan, TaiwanDepartment of Surgery, New Taipei Municipal Tucheng Hospital, New Taipei City, Taiwan PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Chi-Neu Tsai; pink7{at}cgu.edu.tw
View Full Text

Citation

Lin C, Lee Y, Huang Y, et al
Methylation status of vault RNA 2-1 promoter is a predictor of glycemic response to glucagon-like peptide-1 analog therapy in type 2 diabetes mellitus

Publication history

  • Received March 28, 2020
  • Revised January 28, 2021
  • Accepted February 7, 2021
  • First published March 5, 2021.
Online issue publication 
March 05, 2021
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.